TP53 gene mutations and protein accumulation in primary vaginal carcinomas.
暂无分享,去创建一个
J. Nesland | A. Børresen | H. Skomedal | R. Holm | G. Kristensen | Å. Helland | S. Kooi
[1] R Montesano,et al. Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.
[2] D. Lane,et al. The regulation of p53 function: Steiner award lecture , 1994, International journal of cancer.
[3] R. Mirimanoff,et al. Clinical implications of the p53 tumor-suppressor gene. , 1994, The New England journal of medicine.
[4] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[5] G. Viale,et al. p53 accumulation in ovarian carcinomas and its prognostic implications. , 1993, Human pathology.
[6] H. Fox,et al. Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium , 1993, Histopathology.
[7] J. Nesland,et al. Genetic alterations of the TP53 gene, p53 protein expression and hpv infection in primary cervical carcinomas , 1993, The Journal of pathology.
[8] R. Bast,et al. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. , 1993, Journal of the National Cancer Institute.
[9] P. Humphrey,et al. Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias. , 1993, American journal of obstetrics and gynecology.
[10] K. Heimdal,et al. Prognostic significance of TP53 alterations in breast carcinoma. , 1993, British Journal of Cancer.
[11] M. Fritsche,et al. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.
[12] J. Nesland,et al. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri , 1993, The Journal of pathology.
[13] S. N. Agoff,et al. Regulation of the human hsp70 promoter by p53. , 1993, Science.
[14] G. Zambetti,et al. Wild-type p53 binds to the TATA-binding protein and represses transcription. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[16] L. Edelmann,et al. p53 expression in neoplasms of the uterine corpus. , 1992, American journal of clinical pathology.
[17] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[18] A. Børresen,et al. Papillomaviruses, p53, and cervical cancer , 1992, The Lancet.
[19] W. Mason,et al. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours , 1992, The Lancet.
[20] S. Friend,et al. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[21] K. Münger,et al. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Levine,et al. The p53 tumour suppressor gene , 1991, Nature.
[23] C. Mies,et al. Extraction of DNA from paraffin blocks for Southern blot analysis. , 1991, The American journal of surgical pathology.
[24] A. Brøgger,et al. Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection. , 1991, Mutation research.
[25] H. Ikenberg,et al. Human Papillomavirus DNA in Invasive Carcinoma of the Vagina , 1990, Obstetrics and gynecology.
[26] F. Collins,et al. Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.
[27] M. Uhlén,et al. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. , 1989, Nucleic acids research.
[28] A. Levine,et al. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.
[29] S. Hsu,et al. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. , 1981, American journal of clinical pathology.
[30] D. Lane,et al. T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.
[31] A. Schultz,et al. Primary Invasive Squamous Carcinoma of the Vagina , 1979, Obstetrics and gynecology.
[32] James H. Ware,et al. On distribution-free tests for equality of survival distributions , 1977 .
[33] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .